Adar1-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
198
Total Value
523731625
Accession Number
0001940272-25-000003
Form Type
13F-HR
Manager Name
Adar1-Capital-Management
Data Enrichment
82% identified
163 identified35 unidentified

Holdings

198 positions
Manager:
Search and click to pin securities to the top
Page 8 of 10
MoonLake Immunotherapeutics
Shares:5.4K
Value:$211.9K
Stoke Therapeutics, Inc.
Shares:30.1K
Value:$200.1K
G2283U100
Shares:18.5K
Value:$197.2K
Quince Therapeutics, Inc.
Shares:143.0K
Value:$190.1K
Denali Therapeutics Inc.
Shares:13.9K
Value:$188.6K
Wave Life Sciences Ltd.
Shares:23.1K
Value:$186.6K
BiomX Inc.
Shares:299.6K
Value:$166.5K
Kura Oncology, Inc.
Shares:25.0K
Value:$165.0K
Acumen Pharmaceuticals, Inc.
Shares:146.2K
Value:$160.8K
Organon & Co.
Shares:10.0K
Value:$148.9K
28658R106
Shares:119.3K
Value:$145.6K
ANAVEX LIFE SCIENCES CORP.
Shares:16.2K
Value:$139.2K
Immunome Inc.
Shares:20.0K
Value:$134.6K
Solid Biosciences Inc.
Shares:34.5K
Value:$127.6K
SPRUCE BIOSCIENCES, INC.
Shares:403.7K
Value:$117.1K
ACHIEVE LIFE SCIENCES, INC.
Shares:43.2K
Value:$115.3K
VYNE Therapeutics Inc.
Shares:70.4K
Value:$111.3K
PMV Pharmaceuticals, Inc.
Shares:101.0K
Value:$110.1K
29286M105
Shares:23.8K
Value:$106.6K
ALGONQUIN POWER & UTILITIES CORP.
Shares:20.0K
Value:$102.8K